Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 3/20 | 0.47 |
| ▸ | DRD4 | P21917 | 3/20 | 0.47 |
| ▸ | DRD3 | P35462 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.45 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.45 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14173881 | 0.90 | KCNH2 (0.65) | KCNH2PPARDPPARAL3MBTL1KMT2A | |
| SCHEMBL8389299 | 0.89 | DRD2 (0.53) | KCNH2L3MBTL1KMT2ADRD2DRD4 | |
| Hydrochloric Acid SCHEMBL27900832 | 0.88 | KCNH2 (0.62) | KCNH2PPARDPPARAL3MBTL1KMT2A | |
| SCHEMBL28638094 | 0.85 | KCNH2 (0.56) | KCNH2PPARDPPARAL3MBTL1KMT2A | |
| SCHEMBL19012412 | 0.83 | KMT2A (0.60) | KCNH2PPARDPPARAKMT2ADRD2 | |
| SCHEMBL22894194 | 0.83 | KMT2A (0.60) | KCNH2PPARDPPARAKMT2ADRD2 | |
| SCHEMBL5391064 | 0.83 | FFAR1 (0.67) | FFAR1NPC1RAB9A | |
| SCHEMBL22894151 | 0.83 | DRD2 (0.62) | KCNH2PPARDPPARAL3MBTL1KMT2A | |
| SCHEMBL15079877 | 0.83 | DRD2 (0.62) | KCNH2PPARDPPARAL3MBTL1KMT2A | |
| SCHEMBL11135881 | 0.81 | NPC1 (0.68) | KCNH2PPARDPPARAKMT2ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9974869-B2 | Chelated PSMA inhibitors | CANCER TARGETED TECHNOLOGY LLC (US) | 2018-05-22 | — | — | US | disclosed |
| US-20170072075-A1 | Chelated PSMA Inhibitors | CANCER TARGETED TECHNOLOGY LLC | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170072075-A1 | Chelated PSMA Inhibitors | FOLH1, KLK3, PSMA1 | KCNH2 4677/4885PPARD 1891/4885PPARA 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.